Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aratana Therapeutics Inc (NASDAQ:PETX)

6.55
Delayed Data
As of Feb 24
 -0.04 / -0.61%
Today’s Change
3.15
Today|||52-Week Range
10.73
-8.77%
Year-to-Date
No recent news for Aratana Therapeutics Inc.

Today’s Trading

Previous close6.59
Today’s open6.52
Day’s range6.47 - 6.60
Volume263,445
Average volume (3 months)492,400
Market cap$242.6M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-88.46%
Earnings growth (this year)+70.61%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-11.60%
P/E ratioNM
Price/Sales282.75
Price/Book2.23

Competitors

 Today’s
change
Today’s
% change
TTPHTetraphase Pharmaceu...+0.13+2.50%
MNKDMannKind Corp+0.01+2.61%
IDRAIdera Pharmaceutical...-0.06-3.47%
OCULOcular Therapeutix I...-0.07-0.85%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$678.0K
Annual profit (last year)-$84.1M
Net profit margin-12,397.35%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Operating Officer
Brent A. Standridge
Corporate headquarters
Leawood, Kansas

Forecasts


Search for Jobs